ArticleFrontiers in endocrinology2025
Development and validation of prediction models for special subtype of primary aldosteronism: patients with negative adrenal CT imaging.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Current subtype diagnosis of primary aldosteronism relies on adrenal venous sampling and imaging, each with inherent limitations. Lesional adrenal glands with negative CT Imaging is a distinct subtype of primary aldosteronism that has been less frequently studied. The aim of this study was to develop and validate a machine learning and AI model for distinguishing adrenals with transversely negative lesions from normal adrenals Primary Aldosteronism. Materials and methods: We conducted a single-center retrospective study, assessing transverse adrenal scans of 170 PA patients. A specialized iterative method was employed for radiomic feature selection. Subsequently, six conventional machine learning methodologies were utilized to construct the radiomics models. This original data was subsequently applied in the construction of a radiomic model, which was combined with clinical data for the final model construction. Results: 107 radiomic features were extracted from the adrenal scans and 10 features were selected for ML and AI modeling. In the clinical data, values for serum potassium, aldosterone excretion, uric acid, and IVSd were utilized in the model construction. The integration of clinical data further enhanced the model's performance, with an AUC reaching 0.868 in the derived cohort, and an AUC of 0.853 in the temporal validation cohort. Conclusion: The study indicates that clinical-radiomic scores can independently serve as diagnostic biomarkers for the specialized PA subtype categorization. We give the proposal for the precise categorization concept in establishing a clinical-radiomic model for PA subtype diagnosis. The model demonstrates substantial potential for both clinical and translational research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.